Your browser doesn't support javascript.
loading
Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex - United States, March 2019 - December 2020.
Cremer, Laura J; Board, Amy; Guy, Gery P; Schieber, Lyna; Asher, Alice; Parker, Erin M.
Afiliação
  • Cremer LJ; Division of Overdose Prevention, National Center for Injury Prevention and Control, Atlanta, GA, USA. Electronic address: qah6@cdc.gov.
  • Board A; Division of Overdose Prevention, National Center for Injury Prevention and Control, Atlanta, GA, USA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Guy GP; Division of Overdose Prevention, National Center for Injury Prevention and Control, Atlanta, GA, USA.
  • Schieber L; Division of Overdose Prevention, National Center for Injury Prevention and Control, Atlanta, GA, USA.
  • Asher A; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA, USA.
  • Parker EM; Division of Overdose Prevention, National Center for Injury Prevention and Control, Atlanta, GA, USA.
Drug Alcohol Depend ; 232: 109192, 2022 03 01.
Article em En | MEDLINE | ID: mdl-35065513

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmácia / Buprenorfina / COVID-19 / Transtornos Relacionados ao Uso de Opioides Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmácia / Buprenorfina / COVID-19 / Transtornos Relacionados ao Uso de Opioides Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article